Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Xiaoping Zhou

Showing results (181-190 of 188) with videos related to

Pageof 19
Sort By:
You have reached the last page of results.This site can display upto 188 results.
The Journal of Pharmacology and Experimental Therapeutics|February 26, 2020
Pharmacological Characterization of the Novel and Selective <i>α</i>7 Nicotinic Acetylcholine Receptor-Positive Allosteric Modulator BNC375Xiaohai Wang, Christopher Daley, Vanita Gakhar, et al.
Neurobiology of Pain (Cambridge, Mass.)|April 11, 2025
Humanized Na<sub>V</sub>1.8 rats overcome cross-species potency shifts in developing novel Na<sub>V</sub>1.8 inhibitorsDillon S McDevitt, Joshua D Vardigan, Xiaoping Zhou, et al.
The Journal of Pharmacology and Experimental Therapeutics|September 27, 2015
MLi-2, a Potent, Selective, and Centrally Active Compound for Exploring the Therapeutic Potential and Safety of LRRK2 Kinase InhibitionMatthew J Fell, Christian Mirescu, Kallol Basu, et al.
Bioorganic & Medicinal Chemistry Letters|June 29, 2010
T-type calcium channel blockers: spiro-piperidine azetidines and azetidinones-optimization, design and synthesisElizabeth M Smith, Steve Sorota, Hyunjin M Kim, et al.
ACS Medicinal Chemistry Letters|May 20, 2026
Discovery of MK-5661, a Once-Daily Oral Na<sub>V</sub>1.8 Inhibitor for the Treatment of PainChristopher J Bungard, Michael J Breslin, Christopher W Boyce, et al.
Nature|August 2, 2019
Plant cell-surface GIPC sphingolipids sense salt to trigger Ca<sup>2+</sup> influxZhonghao Jiang, Xiaoping Zhou, Ming Tao, et al.
Journal of Medicinal Chemistry|December 21, 2021
Development of ProTx-II Analogues as Highly Selective Peptide Blockers of Na<sub>v</sub>1.7 for the Treatment of PainGregory L Adams, Parul S Pall, Steven M Grauer, et al.
Journal of Medicinal Chemistry|March 1, 2017
Discovery of a 3-(4-Pyrimidinyl) Indazole (MLi-2), an Orally Available and Selective Leucine-Rich Repeat Kinase 2 (LRRK2) Inhibitor that Reduces Brain Kinase ActivityJack D Scott, Duane E DeMong, Thomas J Greshock, et al.
Pageof 19

Showing results (181-190 of 188) with videos related to

Sort By:
Pageof 19
You have reached the last page of results.This site can display upto 188 results.
The Journal of Pharmacology and Experimental Therapeutics|February 26, 2020
Pharmacological Characterization of the Novel and Selective <i>α</i>7 Nicotinic Acetylcholine Receptor-Positive Allosteric Modulator BNC375Xiaohai Wang, Christopher Daley, Vanita Gakhar, et al.
Neurobiology of Pain (Cambridge, Mass.)|April 11, 2025
Humanized Na<sub>V</sub>1.8 rats overcome cross-species potency shifts in developing novel Na<sub>V</sub>1.8 inhibitorsDillon S McDevitt, Joshua D Vardigan, Xiaoping Zhou, et al.
The Journal of Pharmacology and Experimental Therapeutics|September 27, 2015
MLi-2, a Potent, Selective, and Centrally Active Compound for Exploring the Therapeutic Potential and Safety of LRRK2 Kinase InhibitionMatthew J Fell, Christian Mirescu, Kallol Basu, et al.
Bioorganic & Medicinal Chemistry Letters|June 29, 2010
T-type calcium channel blockers: spiro-piperidine azetidines and azetidinones-optimization, design and synthesisElizabeth M Smith, Steve Sorota, Hyunjin M Kim, et al.
ACS Medicinal Chemistry Letters|May 20, 2026
Discovery of MK-5661, a Once-Daily Oral Na<sub>V</sub>1.8 Inhibitor for the Treatment of PainChristopher J Bungard, Michael J Breslin, Christopher W Boyce, et al.
Nature|August 2, 2019
Plant cell-surface GIPC sphingolipids sense salt to trigger Ca<sup>2+</sup> influxZhonghao Jiang, Xiaoping Zhou, Ming Tao, et al.
Journal of Medicinal Chemistry|December 21, 2021
Development of ProTx-II Analogues as Highly Selective Peptide Blockers of Na<sub>v</sub>1.7 for the Treatment of PainGregory L Adams, Parul S Pall, Steven M Grauer, et al.
Journal of Medicinal Chemistry|March 1, 2017
Discovery of a 3-(4-Pyrimidinyl) Indazole (MLi-2), an Orally Available and Selective Leucine-Rich Repeat Kinase 2 (LRRK2) Inhibitor that Reduces Brain Kinase ActivityJack D Scott, Duane E DeMong, Thomas J Greshock, et al.
Pageof 19